<?xml version="1.0" encoding="UTF-8"?>
<p>The 
 <italic>in vitro</italic> antiproliferative or cytotoxic activity of extracts and compounds from 
 <italic>E. chinense</italic>, 
 <italic>E. robustum</italic> and 
 <italic>E. griseum</italic> against various cancer cell lines has been reported suggesting some preliminary potential for cancer treatment. Using the MTT (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide) cell viability assay, a hexane root extract of 
 <italic>E. chinense</italic> exhibited a moderate cytotoxic activity against human small-cell lung (NCI-H187) (IC
 <sub>50</sub> of 12.0 μg/ml) and oral epidermal carcinoma (KB) (IC
 <sub>50</sub> of 9.9 μg/ml) cells. Normal monkey kidney Vero cells were also moderately (IC
 <sub>50</sub>: 5.8 μg/ml) affected (
 <xref rid="B166" ref-type="bibr">Sutthivaiyakit et al., 2009</xref>). Khonklonginols A (
 <bold>27</bold>), F (
 <bold>19</bold>) and H (
 <bold>38</bold>), lupinifolinol (
 <bold>23</bold>), dehydrolupinifolinol (
 <bold>18</bold>) and flemichin D (
 <bold>40</bold>) from the roots of 
 <italic>E. chinense</italic> exhibited a strong cytotoxicity (IC
 <sub>50</sub> of 2.4–3.9 μg/ml) toward NCI-H187 cells while khonklonginol B (
 <bold>28</bold>), lupinifolin (
 <bold>39</bold>) and eriosemaone A (
 <bold>34</bold>) with IC
 <sub>50</sub> values of 4.3, 6.5 and 6.0 μg/ml, respectively, were moderately cytotoxic (
 <xref rid="B166" ref-type="bibr">Sutthivaiyakit et al., 2009</xref>). Toward KB cells, compounds 
 <bold>23, 27</bold>, 
 <bold>28</bold>, 
 <bold>39</bold> and 
 <bold>40</bold> displayed a strong cytotoxic effect, while 
 <bold>18</bold>, 
 <bold>19</bold>, 
 <bold>34</bold> and 
 <bold>38</bold> showed a moderate effect. Compounds 
 <bold>18</bold>, 
 <bold>19</bold>, 
 <bold>27</bold> and 
 <bold>38</bold> displayed a significant cytotoxicity (IC
 <sub>50</sub> of 6.4–11.1 μg/ml) toward Vero cells.
</p>
